Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study - Moebus, V; Jackisch, C; Lueck, H J (J Clin Oncol, 2010)